Login / Signup

PARC report: health outcomes and value of personalized medicine interventions: impact on patient care.

Christina MitropoulouVeronika LitinskiBoyko KabakchievSara RogersGeorge P Patrinos
Published in: Pharmacogenomics (2020)
The incorporation of personalized medicine interventions into routine healthcare constitutes an opportunity to improve patients' quality of life, as it empowers implementation of innovative, individualized clinical interventions that maximize efficacy and/or minimize the risk of adverse drug reactions. In order to ensure equal access to genomic testing for all patients, the costs associated with these interventions must be reimbursed by payers and insurance bodies. As such, it is of utmost importance to thoroughly evaluate these interventions both in terms of their clinical effectiveness and their economic cost. This article discusses the impact of personalized medicine interventions in terms of both health outcomes and value, which directly impacts on their pricing and reimbursement by the various national healthcare systems.
Keyphrases
  • healthcare
  • physical activity
  • end stage renal disease
  • ejection fraction
  • adverse drug
  • newly diagnosed
  • randomized controlled trial
  • prognostic factors
  • systematic review
  • gene expression
  • primary care
  • dna methylation